All stocks ยท EVERESTO
EO

Everest Organics Ltd.

EVERESTO BSE Drug Manufacturers - Specialty & Generic Healthcare

Everest Organics Limited engages in the manufacture and sale of active pharmaceutical ingredients and its intermediaries in India. It is also involved in the manufacturing of bulk drugs-related business. The company expโ€ฆ

ISIN INE334C01029
Listed โ€”
Quarters tracked 13
Filings 20 docs

About

Everest Organics Limited engages in the manufacture and sale of active pharmaceutical ingredients and its intermediaries in India. It is also involved in the manufacturing of bulk drugs-related business. The company exports its products. Everest Organics Limited was incorporated in 1993 and is based in Hyderabad, India.

Key Metrics

as of Sep 2026
Market Cap272 Cr
P/E51.70
Div Yield0.00 %
Book Valueโ‚น77.70
52w Highโ‚น536.00
52w Lowโ‚น197.00
Face Valueโ‚น10.00

Quarterly Results

Rs. Crores ยท hover row for definition
Metric Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023 Jun 2023
Sales 48.43 48.75 42.59 51.00 53.81 40.93 42.05 44.05 32.45 52.62 52.51 49.45 42.67
Expenses 44.10 42.05 39.05 45.87 49.37 37.49 38.03 40.62 36.11 49.67 49.71 46.74 40.15
Operating Profit 4.33 6.70 3.54 5.13 4.44 3.44 4.02 3.43 -3.66 2.95 2.80 2.71 2.52
OPM % 8.94 13.74 8.31 10.06 8.25 8.40 9.56 7.79 -11.28 5.61 5.33 5.48 5.91
Other Income 0.42 0.16 0.25 0.29 0.55 0.22 0.00 0.14 0.33 0.30 0.13 0.24 0.22
Depreciation 1.59 1.93 1.52 1.52 1.52 1.56 1.47 1.47 1.47 1.85 1.33 1.32 1.29
Interest 1.63 2.76 1.23 1.23 1.31 1.15 1.40 1.35 1.29 1.24 1.45 1.49 1.29
Profit before tax 1.53 2.17 1.04 2.67 2.16 0.95 1.15 0.75 -6.09 0.16 0.15 0.14 0.16
Tax % 26.80 -21.20 65.38 56.93 35.19 -206.32 0.87 1.33 0.00 62.50 93.33 78.57 75.00
Net Profit 1.11 2.63 0.36 1.16 1.41 2.91 1.14 0.74 -6.09 0.06 0.02 0.03 0.04
EPS in Rs 1.14 2.71 0.37 1.19 1.45 3.00 1.42 0.92 -7.61 0.08 0.02 0.04 0.05

Profit & Loss

Annual ยท Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Sales 196.00159.00197.00183.00200.00182.00167.00156.00112.00107.0099.00106.00
Expenses 176.00152.00186.00182.00194.00159.00148.00138.00105.00101.0094.0098.00
Operating Profit 20.007.0011.001.006.0023.0019.0018.007.006.006.008.00
OPM % 10.004.506.000.503.2013.0011.0011.006.006.006.007.00
Other Income 1.001.001.007.002.001.001.001.001.001.000.000.00
Interest 7.005.005.003.003.003.003.003.003.003.003.003.00
Depreciation 6.006.006.004.004.003.003.003.003.002.003.003.00
Profit before tax 8.00-3.001.000.002.0017.0014.0012.002.002.000.002.00
Tax % 31.00-60.0077.00311.0034.0021.0023.0039.0028.0024.0018.0020.00
Net Profit 6.00-1.000.000.001.0014.0011.008.002.001.000.002.00
EPS in Rs 5.72-1.330.18-0.221.4217.1513.629.392.141.690.54โ€”
Dividend Payout % 0.000.000.000.000.009.007.0011.000.000.000.000.00

Balance Sheet

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Equity Capital 10.0010.008.008.008.008.008.008.008.008.003.009.00
Reserves 66.0060.0038.0038.0039.0039.0026.0018.0011.008.003.00-3.00
Borrowings 50.0048.0058.0051.0039.0023.0018.0021.0022.0019.0028.0024.00
Other Liabilities 114.00107.00123.00105.0092.0066.0068.0060.0054.0051.0042.0037.00
Total Liabilities 240.00224.00227.00202.00178.00135.00120.00107.0094.0086.0076.0067.00
Fixed Assets 48.0050.0052.0054.0049.0044.0039.0038.0034.0033.0027.0024.00
CWIP 21.0023.0021.0012.008.000.001.000.001.001.001.000.00
Investments 0.000.000.000.000.000.000.000.000.000.000.000.00
Other Assets 171.00152.00153.00136.00121.0092.0080.0068.0060.0052.0047.0042.00
Total Assets 240.00224.00227.00202.00178.00135.00120.00107.0094.0086.0076.0067.00

Cash Flows

Annual ยท Rs. Crores โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Cash from Operating Activity 4.00-5.0016.0018.0014.0014.0010.009.005.0010.007.004.00
Cash from Investing Activity -2.00-5.00-13.00-16.00-17.00-12.00-6.00-5.00-4.00-8.00-7.00-3.00
Cash from Financing Activity -8.0016.00-3.00-3.002.00-2.00-3.00-3.00-1.00-2.000.00-2.00
Net Cash Flow -6.006.000.000.00-1.000.000.001.000.000.000.000.00
Free Cash Flow 2.00-11.003.005.00-3.007.003.002.001.002.000.001.00
CFO/OP % 21.00-76.00149.001,981.00214.0059.0051.0050.0064.00162.00119.0052.00

Ratios

Annual ยท Days / % โ€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
Debtor Days 216.00202.00185.00152.00125.00102.0097.0095.00124.00105.00117.00100.00
Inventory Days 133.00166.00128.00139.00110.00110.00102.0071.0072.0073.0055.0044.00
Days Payable 264.00351.00324.00282.00212.00183.00211.00190.00251.00260.00235.00184.00
Cash Conversion Cycle 85.0017.00-11.009.0024.0029.00-12.00-24.00-55.00-83.00-63.00-40.00
Working Capital Days 27.003.00-20.00-12.009.0021.007.00-15.00-34.00-50.00-38.00-30.00
ROCE % 12.002.006.004.006.0034.0035.0035.0013.0013.0011.0019.00

Shareholding Pattern

% holding โ€” latest first
Holder Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024 Jun 2024 Mar 2024 Dec 2023 Sep 2023
Promoters 59.60 59.58 59.61 59.64 60.99 61.09 74.15 74.15 74.15 74.15 74.15 74.15
DIIs 0.02 0.02 0.02 0.02 0.02 0.02 0.05 0.05 0.03 0.03 0.03 0.03
Public 40.38 40.40 40.36 40.35 38.99 38.90 25.80 25.81 25.83 25.83 25.82 25.82
No. of Shareholders 7,827 7,880 7,804 8,079 8,281 8,756 9,326 9,996 9,792 10,023 10,242 10,494

Corporate Actions

6 records
ActionEx DateRecord DateRatioAmount (โ‚น)Notes
Dividend 15 Sep 2022 โ€” โ€” 0.50
Dividend 08 Sep 2021 โ€” โ€” 1.00
Dividend 17 Feb 2021 18 Feb 2021 โ€” 0.50
Dividend 01 Sep 2020 โ€” โ€” 1.00
Dividend 03 Sep 2019 โ€” โ€” 1.00
Other 12 Aug 2015 13 Aug 2015 โ€” โ€” Reduction of Capital

Announcements

5 filings